Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Cullinan Therapeutics, Inc.(CGEM) | 9,731,341 | 9,721,081 | -10,260 | $177.21M | $149.22M | 11.49% | -$27.99M |
| Aktis Oncology, Inc.(AKTS) | 4,835,872 | 4,835,872 | 0 | $155.86M | $94.15M | 7.25% | -$61.71M |
| Travere Therapeutics, Inc.(TVTX) | 1,122,731 | 1,088,363 | -34,368 | $63.78M | $64.08M | 4.93% | +$300.5K |
| Edgewise Therapeutics, Inc.(EWTX) | 1,620,780 | 1,575,987 | -44,793 | $65.85M | $63.99M | 4.93% | -$1.87M |
| Dyne Therapeutics, Inc.(DYN) | 1,922,093 | 3,208,146 | +1,286,053 | $42.69M | $51.68M | 3.98% | +$8.99M |
| Corcept Therapeutics Incorporated(CORT) | 771,028 | 422,000 | -349,028 | $67.04M | $48.63M | 3.74% | -$18.41M |
| Relay Therapeutics, Inc.(RLAY) | 2,415,672 | 2,369,578 | -46,094 | $45.20M | $42.77M | 3.29% | -$2.43M |
| Trevi Therapeutics, Inc.(TRVI) | 3,073,577 | 2,978,906 | -94,671 | $57.32M | $42.66M | 3.28% | -$14.66M |
| Iovance Biotherapeutics, Inc.(IOVA) | 0 | 2,835,734 | +2,835,734 | $0 | $42.03M | 3.24% | +$42.03M |
| Liquidia Corporation(LQDA) | 1,386,174 | 1,342,713 | -43,461 | $110.52M | $40.63M | 3.13% | -$69.89M |
| Natera, Inc.(NTRA) | 92,638 | 90,585 | -2,053 | $25.15M | $37.44M | 2.88% | +$12.29M |
| UroGen Pharma Ltd.(URGN) | 933,415 | 909,691 | -23,724 | $34.35M | $36.96M | 2.85% | +$2.61M |
| Immunocore Holdings plcADS(IMCR) | 0 | 1,203,289 | +1,203,289 | $0 | $36.45M | 2.81% | +$36.45M |
| DBV Technologies S.A.ADS(DBVT) | 3,666,284 | 3,044,659 | -621,625 | $60.13M | $35.81M | 2.76% | -$24.32M |
| Taysha Gene Therapies, Inc.(TSHA) | 4,500,000 | 7,262,959 | +2,762,959 | $30.64M | $35.37M | 2.72% | +$4.73M |
| ABIVAX Société AnonymeADR(ABVX) | 336,347 | 328,379 | -7,968 | $44.82M | $32.52M | 2.50% | -$12.31M |
| Vir Biotechnology, Inc.(VIR) | 0 | 2,809,711 | +2,809,711 | $0 | $31.41M | 2.42% | +$31.41M |
| Adlai Nortye Group Ltd.ADS(ANL) | 1,936,291 | 1,956,618 | +20,327 | $22.27M | $31.31M | 2.41% | +$9.04M |
| Verastem, Inc.(VSTM) | 0 | 3,851,604 | +3,851,604 | $0 | $31.01M | 2.39% | +$31.01M |
| uniQure N.V.(QURE) | 1,225,855 | 1,201,413 | -24,442 | $56.46M | $29.03M | 2.23% | -$27.44M |
| Odyssey Therapeutics, Inc. | 0 | 1,289,091 | +1,289,091 | $0 | $28.64M | 2.20% | +$28.64M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 322,007 | 352,676 | +30,669 | $20.27M | $27.72M | 2.13% | +$7.46M |
| Palvella Therapeutics, Inc.(PVLA) | 204,027 | 197,633 | -6,394 | $31.18M | $27.26M | 2.10% | -$3.92M |
| Aclaris Therapeutics, Inc.(ACRS) | 1,042,467 | 5,178,127 | +4,135,660 | $5.51M | $27.24M | 2.10% | +$21.72M |
| Oruka Therapeutics, Inc.(ORKA) | 0 | 300,000 | +300,000 | $0 | $24.99M | 1.92% | +$24.99M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 1,882,162 | 1,821,951 | -60,211 | $20.38M | $24.54M | 1.89% | +$4.16M |
| Stoke Therapeutics, Inc.(STOK) | 723,314 | 925,133 | +201,819 | $23.67M | $24.05M | 1.85% | +$386.6K |
| Belite Bio, IncADR(BLTE) | 137,208 | 133,387 | -3,821 | $21.13M | $22.65M | 1.74% | +$1.52M |
| Neurogene Inc.(NGNE) | 0 | 771,839 | +771,839 | $0 | $21.47M | 1.65% | +$21.47M |
| Zura Bio LimitedCL A(ZURA) | 4,472,843 | 4,449,671 | -23,172 | $26.39M | $18.51M | 1.42% | -$7.88M |
| Annexon, Inc.(ANNX) | 3,544,354 | 4,290,616 | +746,262 | $20.24M | $18.15M | 1.40% | -$2.09M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 1,161,081 | 1,125,216 | -35,865 | $28.10M | $13.42M | 1.03% | -$14.67M |
| BioAge Labs, Inc.(BIOA) | 1,667,661 | 1,856,748 | +189,087 | $40.87M | $13.16M | 1.01% | -$27.71M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 0 | 1,667,272 | +1,667,272 | $0 | $11.37M | 0.88% | +$11.37M |
| Bright Minds Biosciences Inc.(DRUG) | 202,114 | 195,669 | -6,445 | $14.19M | $9.75M | 0.75% | -$4.44M |
| First Tracks Biotherapeutics Inc | 0 | 254,374 | +254,374 | $0 | $9.02M | 0.69% | +$9.02M |
| Alumis Inc | 2,019,020 | 0 | -2,019,020 | $56.82M | $0 | — | -$56.82M |
| Context Therapeutics Inc.21077P108(CNTX) | 1,299,046 | 0 | -1,299,046 | $719.5K | $0 | — | -$719.5K |
| Dianthus Therapeutics, Inc.(DNTH) | 420,002 | 0 | -420,002 | $40.94M | $0 | — | -$40.94M |
| Entrada Therapeutics, Inc.29384C108(TRDA) | 1,253,053 | 0 | -1,253,053 | $9.22M | $0 | — | -$9.22M |
| Forte Biosciences, Inc.34962G208 | 987,448 | 0 | -987,448 | $20.98M | $0 | — | -$20.98M |
| MoonLake Immunotherapeutics61559X104(MLTX) | 1,606,967 | 0 | -1,606,967 | $31.29M | $0 | — | -$31.29M |
| Revolution Medicines, Inc.76155X100(RVMD) | 492,483 | 0 | -492,483 | $92.23M | $0 | — | -$92.23M |
| Syndax Pharmaceuticals, Inc.87164F105(SNDX) | 1,333,523 | 0 | -1,333,523 | $29.15M | $0 | — | -$29.15M |
| Ultragenyx Pharmaceutical Inc.90400D108(RARE) | 1,418,215 | 0 | -1,418,215 | $47.35M | $0 | — | -$47.35M |
| Werewolf Therapeutics, Inc.95075A107(HOWL) | 80,142 | 0 | -80,142 | $28.9K | $0 | — | -$28.9K |